All News

One patient with breast implant-associated anaplastic large cell lymphoma spoke out for herself throughout therapy — and encourages other patients do the same.

A cancer survivor remembers his wife who died of complications from ovarian cancer on Valentine’s Day several years ago. His advice to everyone: Holidays gradually become positive reflections of all that was good before cancer took it away.

The results of the phase 3 trial, according to one expert, support the use of Lenvima with Keytruda as a possible first-line treatment option for patients with advanced renal cell carcinoma.

Treatment with sapanisertib was associated with limited activity and poor safety outcomes in patients with refractory metastatic renal cell carcinoma.

For patients to maintain or improve their quality of life through their cancer treatment, it is pivotal that they communicate with their health care team.

A cancer survivor notes how her 16-year-old dog makes it up the steps faster than she does. And although she recognizes she’s getting older, she highlights the side effects of her medications are muscle and joint pain.

The FDA approved Cosela, a first-in-its-class therapy to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage small cell lung cancer.

Clinical trials remain the gold standard when it comes to finding new treatment options for patients, particularly when it comes to renal cell carcinoma. But even if the results are positive and this combination proves to be beneficial, patients should still discuss all of their options with their oncologist to find the right sequence of treatment, says one expert.

The combination of Erleada, Zytiga and the steroid prednisone was associated with a trend toward better survival outcomes in certain patients with chemotherapy-naive metastatic castration-resistant prostate cancer.

Front-line treatment with Opdivo plus Cabometyx improved health-related quality of life outcomes in patients with advanced renal cell carcinoma.

Instead of buying your sweetheart chocolates for Valentine’s Day this year, one cancer survivor suggests people get screened as a gift to their significant other.

From a 12-year-old girl living out her dream of living on the beach after 10 years of neuroblastoma treatments to Alex Trebek’s legacy living on after his passing, here’s what’s happening in the cancer space this week.

On behalf of the National Pancreas Foundation, Dr. Andrew M. Lowy offers background on treatments and outcomes for pancreatic cancer.

Blood shortages during the COVID-19 pandemic have forced cancer centers to get creative to ensure patients with hematologic malignancies are able to get transfusions in a timely manner.

Patients with metastatic non–clear cell renal cell carcinoma who receive immune checkpoint inhibitor–based regimens as a first treatment option may have improved survival, versus those who receive select targeted therapies.

A higher starting dose of Lenvima, compared with a lower starting dose, prolonged the time that patients with renal cell carcinoma experienced negative effects on factors including social and physical functioning, financial difficulties and cogitative functioning over time.

The combination of Lenvima plus everolimus was found to be an acceptable treatment option for patients who have previously received immunotherapy for clear cell renal cell carcinoma, according to the findings of an exploratory analysis of a phase 2 trial presented virtually at the 2021 ASCO Genitourinary Cancers Symposium.

One cancer survivor recalls a recent return trip to the chemo room where he received his treatment seven years ago. This time, it’s to get an IV for a follow-up scan. But he can’t help but reminisce and think of those around him.

This week on the “CURE Talks Cancer” podcast, we spoke with Nicole Schulz, who was diagnosed with acute myeloid leukemia at the age of 14, about how her life changed as a result of her treatment and why she now lives life to the fullest.

Don’t know what to make for lunch? Serve up mung bean sprout salad. And this homemade chicken stock can be used in lots of recipes.

The Food and Drug Administration has granted the investigational therapy asciminib a breakthrough therapy designation for the treatment of certain adults with Philadelphia chromosome-positive chronic myeloid leukemia. The designation may allow for expedited review of the drug.

Theresa Germano sat down with HEAL® to discuss her journey with cancer, how her daughter became her hero and how listening to her body benefited her in the end.

A cancer survivor pens an ode to her port that has made her journey much less stressful.

A patient with cancer recalls how the love her care team showed her during her treatment made such a difference in her journey to recovery. Her hope: That more patients with cancer around the world can find doctors who treat them as a person, and not just a case.

Danielle Ripley-Burgess, a two-time colon cancer survivor, discusses why she wrote a book about her journey and how her experience strengthened her faith.

The Food and Drug Administration has granted an accelerated approval to Libtayo for the treatment of patients with advanced basal cell carcinoma, a type of skin cancer, who were previously treated with a hedgehog pathway inhibitor (HHI) or for whom an HHI was not appropriate.

Doctors have known for some time about cardiotoxicity — the toxic effects that certain cancer treatments have on the heart. Here, we take a closer look.

A penile cancer survivor recalls how he can become irrational and lash out at his loved ones during the days leading up to his next scans. His wish: To be normal again.

Survivors of adolescent or young adult cancer diagnosis experience a 20% higher risk of a psychotic episode and a 30% higher chance of an outpatient mental health visit compared to individuals with no history of cancer.

Women who underwent radiation after cancer surgery had improved distant metastases-free survival rates, although this benefit was not evident in overall survival.